Your browser doesn't support javascript.
loading
SUFU haploinsufficiency causes a recognisable neurodevelopmental phenotype at the mild end of the Joubert syndrome spectrum.
Serpieri, Valentina; D'Abrusco, Fulvio; Dempsey, Jennifer C; Cheng, Yong-Han Hank; Arrigoni, Filippo; Baker, Janice; Battini, Roberta; Bertini, Enrico Silvio; Borgatti, Renato; Christman, Angela K; Curry, Cynthia; D'Arrigo, Stefano; Fluss, Joel; Freilinger, Michael; Gana, Simone; Ishak, Gisele E; Leuzzi, Vincenzo; Loucks, Hailey; Manti, Filippo; Mendelsohn, Nancy; Merlini, Laura; Miller, Caitlin V; Muhammad, Ansar; Nuovo, Sara; Romaniello, Romina; Schmidt, Wolfgang; Signorini, Sabrina; Siliquini, Sabrina; Szczaluba, Krzysztof; Vasco, Gessica; Wilson, Meredith; Zanni, Ginevra; Boltshauser, Eugen; Doherty, Dan; Valente, Enza Maria.
Afiliación
  • Serpieri V; Neurogenetics Research Centre, IRCCS Mondino Foundation, Pavia, Italy.
  • D'Abrusco F; Department of Molecular Medicine, University of Pavia, Pavia, Lombardia, Italy.
  • Dempsey JC; Department of Pediatrics, University of Washington Center for Mendelian Genomics, Washington USA.
  • Cheng YH; Department of Pediatrics, University of Washington Center for Mendelian Genomics, Washington USA.
  • Arrigoni F; Neuroimaging Lab, Scientific Institute IRCCS Eugenio Medea, Bosisio Parini, Lecco, Italy.
  • Baker J; Genomics and Genetic Medicine Department, Children's Minnesota, Minneapolis, Minnesota, USA.
  • Battini R; Unit of Child Neuropsychiatry, IRCCS Foundation Stella Maris, Calambrone, Toscana, Italy.
  • Bertini ES; Department of Clinical ad Experimental Medicine, University of Pisa, Pisa, Italy.
  • Borgatti R; Laboratory of Molecular Medicine, Unit of Muscular and Neurodegenerative Diseases, Department of Neuroscience, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.
  • Christman AK; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Curry C; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.
  • D'Arrigo S; Department of Pediatrics, University of Washington Center for Mendelian Genomics, Washington USA.
  • Fluss J; Department of Pediatrics, Stanford University, Stanford, California, USA.
  • Freilinger M; Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, Fresno, California, USA.
  • Gana S; University Pediatric Specialists, Fresno, California, USA.
  • Ishak GE; Department of Developmental Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Leuzzi V; Department of Women, Children and Adolescents, Geneva University Hospitals, Geneva, Switzerland.
  • Loucks H; Department of Paediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Manti F; Neurogenetics Research Centre, IRCCS Mondino Foundation, Pavia, Italy.
  • Mendelsohn N; Department of Neuroradiology, University of Washington School of Medicine, Seattle, Washington, USA.
  • Merlini L; Pediatric Radiology, Seattle Children's Hospital, Seattle, Washington, USA.
  • Miller CV; Department of Human Neuroscience, University of Rome La Sapienza, Roma, Lazio, Italy.
  • Muhammad A; Department of Pediatrics, University of Washington Center for Mendelian Genomics, Washington USA.
  • Nuovo S; Department of Human Neuroscience, University of Rome La Sapienza, Roma, Lazio, Italy.
  • Romaniello R; Complex Health Solutions, United Healthcare, Minneapolis, Minnesota, USA.
  • Schmidt W; Department of Pediatric Radiology, Geneva University Hospitals Children's Hospital, Geneva, Switzerland.
  • Signorini S; Department of Pediatrics, University of Washington Center for Mendelian Genomics, Washington USA.
  • Siliquini S; Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland.
  • Szczaluba K; Depatment of Ophtalmology, University of Lausanne, Jules Gonin Eye Hospital, Lausanne, Switzerland.
  • Vasco G; Department of Genetic Medicine and Development, University of Geneva, Geneva, Switzerland.
  • Wilson M; Department of Experimental Medicine, University of Rome La Sapienza, Rome, Lazio, Italy.
  • Zanni G; Neuropsychiatry and Neurorehabilitation Unit, Scientific Institute, IRCCS Eugenio Medea, Lecco, Italy.
  • Boltshauser E; Center for Anatomy and Cell Biology, Neuromuscular Research Department, Medical University of Vienna, Vienna, Austria.
  • Doherty D; Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.
  • Valente EM; Child Neuropsychiatry Unit, Paediatric Hospital G Salesi, Ancona, Italy.
J Med Genet ; 59(9): 888-894, 2022 Sep.
Article en En | MEDLINE | ID: mdl-34675124
ABSTRACT

BACKGROUND:

Joubert syndrome (JS) is a recessively inherited ciliopathy characterised by congenital ocular motor apraxia (COMA), developmental delay (DD), intellectual disability, ataxia, multiorgan involvement, and a unique cerebellar and brainstem malformation. Over 40 JS-associated genes are known with a diagnostic yield of 60%-75%.In 2018, we reported homozygous hypomorphic missense variants of the SUFU gene in two families with mild JS. Recently, heterozygous truncating SUFU variants were identified in families with dominantly inherited COMA, occasionally associated with mild DD and subtle cerebellar anomalies.

METHODS:

We reanalysed next generation sequencing (NGS) data in two cohorts comprising 1097 probands referred for genetic testing of JS genes.

RESULTS:

Heterozygous truncating and splice-site SUFU variants were detected in 22 patients from 17 families (1.5%) with strong male prevalence (86%), and in 8 asymptomatic parents. Patients presented with COMA, hypotonia, ataxia and mild DD, and only a third manifested intellectual disability of variable severity. Brain MRI showed consistent findings characterised by vermis hypoplasia, superior cerebellar dysplasia and subtle-to-mild abnormalities of the superior cerebellar peduncles. The same pattern was observed in two out of three tested asymptomatic parents.

CONCLUSION:

Heterozygous truncating or splice-site SUFU variants cause a novel neurodevelopmental syndrome encompassing COMA and mild JS, which likely represent overlapping entities. Variants can arise de novo or be inherited from a healthy parent, representing the first cause of JS with dominant inheritance and reduced penetrance. Awareness of this condition will increase the diagnostic yield of JS genetic testing, and allow appropriate counselling about prognosis, medical monitoring and recurrence risk.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Múltiples / Ataxia Cerebelosa / Anomalías del Ojo / Enfermedades Renales Quísticas / Discapacidad Intelectual Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: J Med Genet Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anomalías Múltiples / Ataxia Cerebelosa / Anomalías del Ojo / Enfermedades Renales Quísticas / Discapacidad Intelectual Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans / Male Idioma: En Revista: J Med Genet Año: 2022 Tipo del documento: Article País de afiliación: Italia
...